Top Markets
Coin of the day
PerkinElmer, Inc. PerkinElmer, Inc.

PerkinElmer, Inc.

PKI
Xếp hạng trong cổ phiếu #1519
PerkinElmer, Inc. operates as a global enterprise delivering innovative... PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Giá cổ phiếu
$120.30
Đồng bộ lần cuối: 2023-05-23
Vốn hóa thị trường
$15.17B
Thay đổi (1 ngày)
0.05%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch PerkinElmer, Inc. (PKI)

Danh mục

EPS của PerkinElmer, Inc. (PKI)
EPS tính đến 2026 TTM: 0
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của PerkinElmer, Inc., EPS hiện tại của công ty (TTM) là 0. Vào cuối năm 2026, công ty có EPS là 0, bằng với EPS năm 2026 là 0.
Lịch sử EPS của PerkinElmer, Inc. từ 2026 đến 2026
EPS vào cuối mỗi năm
Năm EPS Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
Công ty EPS Chênh lệch EPS Quốc gia
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$14.24 -
US